- Home
- GURE vs XTLB Comparison
GURE vs XTLB Comparison
Compare GURE & XTLB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GURE
- XTLB
- Stock Information
- Founded
- GURE 2006
- XTLB 1993
- Country
- GURE China
- XTLB Israel
- Employees
- GURE N/A
- XTLB N/A
- Industry
- GURE Major Chemicals
- XTLB Biotechnology: Pharmaceutical Preparations
- Sector
- GURE Industrials
- XTLB Health Care
- Exchange
- GURE Nasdaq
- XTLB Nasdaq
- Market Cap
- GURE 7.9M
- XTLB 8.0M
- IPO Year
- GURE 1992
- XTLB 2005
- Fundamental
- Price
- GURE $0.62
- XTLB $1.88
- Analyst Decision
- GURE
- XTLB
- Analyst Count
- GURE 0
- XTLB 0
- Target Price
- GURE N/A
- XTLB N/A
- AVG Volume (30 Days)
- GURE 188.6K
- XTLB 108.7K
- Earning Date
- GURE 11-19-2024
- XTLB 12-03-2024
- Dividend Yield
- GURE N/A
- XTLB N/A
- EPS Growth
- GURE N/A
- XTLB N/A
- EPS
- GURE N/A
- XTLB N/A
- Revenue
- GURE $12,802,982.00
- XTLB N/A
- Revenue This Year
- GURE N/A
- XTLB N/A
- Revenue Next Year
- GURE N/A
- XTLB N/A
- P/E Ratio
- GURE N/A
- XTLB N/A
- Revenue Growth
- GURE N/A
- XTLB N/A
- 52 Week Low
- GURE $0.51
- XTLB $0.76
- 52 Week High
- GURE $1.79
- XTLB $4.99
- Technical
- Relative Strength Index (RSI)
- GURE 41.27
- XTLB 48.82
- Support Level
- GURE $0.57
- XTLB $1.67
- Resistance Level
- GURE $0.73
- XTLB $1.85
- Average True Range (ATR)
- GURE 0.07
- XTLB 0.13
- MACD
- GURE 0.00
- XTLB 0.02
- Stochastic Oscillator
- GURE 29.41
- XTLB 72.41
About GURE Gulf Resources Inc. (NV)
Gulf Resources Inc is a holding company engaged in the manufacture and trade of bromine and crude salt, and natural gas; manufactures and sells chemical products used in oil and gas field exploration, oil and gas distribution, oil field drilling, wastewater processing, papermaking chemical agents and inorganic chemicals, and manufactures and sells materials for human and animal antibiotics. It operates in four segments: Bromine, Crude Salt, Chemical Products and Natural Gas. It derives maximum revenue from the Bromine segment which is commonly used in brominated flame retardants, fumigants, water purification compounds, dyes, medicines and disinfectants.
About XTLB XTL Biopharmaceuticals Ltd.
XTL Biopharmaceuticals Ltd is engaged in the development of therapeutics for the treatment of unmet medical needs. Its products include hCDR1 and Recombinant Human Erythropoietin (rHuEPO). hCDR1 is a Phase II-ready asset compound, working through a mechanism of action, for the treatment of Systemic Lupus Erythematosus (SLE) and Sjogren's syndrome. hCDR1 is a synthetic peptide that includes approximately 20 amino-acid residues. rHuEPO, a known agent for anemia, is being developed to prolong the survival of patients with advanced multiple myeloma (MM). rHuEPO is used in clinical practice for the treatment of various anemias, including anemia of kidney disease and cancer-related anemia.